SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-20-000014
Filing Date
2020-05-14
Accepted
2020-05-14 16:21:34
Documents
62
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sls-20200331x10q.htm 10-Q 733403
2 EXHIBIT 10.3 sls20200331ex103.htm EX-10.3 116403
3 EXHIBIT 31.1 sls20200331ex311.htm EX-31.1 11687
4 EXHIBIT 31.2 sls20200331ex312.htm EX-31.2 11641
5 EXHIBIT 32.1 sls20200331ex321.htm EX-32.1 10935
12 sellas-logoa12.jpg GRAPHIC 30719
  Complete submission text file 0001390478-20-000014.txt   4584641

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gale-20200331.xml EX-101.INS 890631
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gale-20200331.xsd EX-101.SCH 42701
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gale-20200331_cal.xml EX-101.CAL 49815
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gale-20200331_def.xml EX-101.DEF 176255
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gale-20200331_lab.xml EX-101.LAB 498006
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gale-20200331_pre.xml EX-101.PRE 300882
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 20878107
SIC: 2834 Pharmaceutical Preparations